Literature DB >> 2505896

Steroid osteoporosis.

I R Reid1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2505896     DOI： 10.1007/bf02561402

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  40 in total

1.  Effect of glucocorticoids on function of the parathyroid glands in man.

Authors:  R F Fucik; S C Kukreja; G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

2.  Studies of the acute effects of aldosterone and cortisol on the interrelationship between renal sodium, calcium and magnesium excretion in normal man.

Authors:  J Lemann; W F Piering; E J Lennon
Journal:  Nephron       Date:  1970       Impact factor: 2.847

3.  Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro.

Authors:  W A Peck; J Brandt; I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

4.  Cortisol decreases bone formation by inhibiting periosteal cell proliferation.

Authors:  Y S Chyun; B E Kream; L G Raisz
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

5.  Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study.

Authors:  K H Nilsen; M I Jayson; A S Dixon
Journal:  Br Med J       Date:  1978-10-21

6.  Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1,25-dihydroxyvitamin D3.

Authors:  J J Feher; R H Wasserman
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

7.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae.

Authors:  E Canalis
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

9.  Bone studies in patients on prolonged systemic corticosteroid therapy for asthma.

Authors:  P A Greenberger; R W Hendrix; R Patterson; J S Chmiel
Journal:  Clin Allergy       Date:  1982-07

10.  Low serum osteocalcin levels in glucocorticoid-treated asthmatics.

Authors:  I R Reid; G E Chapman; T R Fraser; A D Davies; A S Surus; J Meyer; N L Huq; H K Ibbertson
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958
View more
  12 in total

Review 1.  Corticosteroids and osteoporosis.

Authors:  R Smith
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

2.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

3.  Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.

Authors:  L Montemurro; G Schiraldi; P Fraioli; G Tosi; A Riboldi; G Rizzato
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

4.  The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis.

Authors:  M P Seed; C R Gardner
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  Continuing loss of vertebral mineral density in renal transplant recipients.

Authors:  B Bagni; P Gilli; A Cavallini; I Bagni; M C Marzola; C Orzincolo; H W Wahner
Journal:  Eur J Nucl Med       Date:  1994-02

6.  Reversion of the steroid-induced decrease of serum osteocalcin with sodium fluoride.

Authors:  H Rico; J A Cabranes; E R Hernandez; A Barabash; P Romero
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

7.  Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus.

Authors:  Makio Furukawa; Chikako Kiyohara; Hiroshi Tsukamoto; Hiroki Mitoma; Yasutaka Kimoto; Ayumi Uchino; Misato Nakagawa; Kensuke Oryoji; Terufumi Shimoda; Koichi Akashi; Mine Harada; Takahiko Horiuchi
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

8.  Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Authors:  K Olgaard; T Storm; N van Wowern; H Daugaard; M Egfjord; E Lewin; L Brandi
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

Review 9.  Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.

Authors:  A Hodsman; J Adachi; W Olszynski
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262

10.  Experimental changes in mineral content of juvenile mouse femora.

Authors:  K R Gordon; P Burns; G Keller
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.